A carregar...
PM-04 IN SILICO ANALYSIS OF AVAglio AND RTOG 0825 PHASE III CLINICAL TRIALS SUGGESTS SIGNATURES OF PATIENTS TO RECEIVE BENEFIT FROM COMBINED BEVACIZUMAB AND RADIATION THERAPIES
Despite the growing interest in anti-angiogenic therapies for glioblastoma (GBM), no statistically significant evidence has been found to indicate that bevacizumab in combination with other therapies increases the overall survival of glioblastoma patients. Most recently two phase III trials, AVAglio...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4218487/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou268.4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|